XPO1 and thymoma: IHC analysis of 132 TET tumors and 16 normal thymic tissues revealed an association between a higher expression of XPO1 and more aggressive histologic subtypes (e.g., B2/B3 thymoma and thymic carcinoma) and advanced stages of disease.